AAAAAA

   
Results: 1-19 |
Results: 19
New strategy developments in brain tumor therapy
Authors: Brandes, AA Basso, U Pasetto, LM Ermani, M
Citation: Aa. Brandes et al., New strategy developments in brain tumor therapy, CUR PHARM D, 7(16), 2001, pp. 1553-1580
Future trends in the treatment of brain tumours
Authors: Brandes, AA Lacombe, D Vecht, C
Citation: Aa. Brandes et al., Future trends in the treatment of brain tumours, EUR J CANC, 37(18), 2001, pp. 2297-2301
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
Authors: Brandes, AA Ermani, M Basso, U Amista, P Berti, F Scienza, R Rotilio, A Pinna, G Gardiman, M Monfardini, S
Citation: Aa. Brandes et al., Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study, ANN ONCOL, 12(2), 2001, pp. 255-257
Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection
Authors: Lumachi, F Ferretti, G Povolato, M Marzola, MC Zucchetta, P Geatti, O Bui, F Brandes, AA
Citation: F. Lumachi et al., Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection, EUR J SUR O, 27(3), 2001, pp. 256-259
High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults
Authors: Brandes, AA Palmisano, V Pasetto, LM Basso, U Monfardini, S
Citation: Aa. Brandes et al., High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults, CANCER INV, 19(1), 2001, pp. 41-48
Sestamibi scintimammography in pT1 breast cancer: Alternative or complementary to X-ray mammography?
Authors: Lumachi, F Ferretti, G Povolato, M Marzola, MC Zucchetta, P Geatti, O Bui, F Brandes, AA
Citation: F. Lumachi et al., Sestamibi scintimammography in pT1 breast cancer: Alternative or complementary to X-ray mammography?, ANTICANC R, 21(3C), 2001, pp. 2201-2205
Temozolomide chemotherapy in recurrent oligodendroglioma
Authors: van den Bent, MJ Keime-Guibert, F Brandes, AA Taphoorn, MJB Kros, JM Eskens, FALM Carpentier, AF
Citation: Mj. Van Den Bent et al., Temozolomide chemotherapy in recurrent oligodendroglioma, NEUROLOGY, 57(2), 2001, pp. 340-342
Fine-needle aspiration cytology of adrenal masses in noncancer patients - Clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors
Authors: Lumachi, F Borsato, S Brandes, AA Boccagni, P Tregnaghi, A Angelini, F Favia, G
Citation: F. Lumachi et al., Fine-needle aspiration cytology of adrenal masses in noncancer patients - Clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors, CANC CYTOP, 93(5), 2001, pp. 323-329
Radiotherapy of the brain in elderly patients - Contra
Authors: Brandes, AA Rigon, A Monfardini, S
Citation: Aa. Brandes et al., Radiotherapy of the brain in elderly patients - Contra, EUR J CANC, 36(4), 2000, pp. 447-451
The treatment of cranial germ cell tumours
Authors: Brandes, AA Pasetto, LM Monfardini, S
Citation: Aa. Brandes et al., The treatment of cranial germ cell tumours, CANC TR REV, 26(4), 2000, pp. 233-242
Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors
Authors: Lumachi, F Brandes, AA Ermani, M Bruno, G Boccagni, P
Citation: F. Lumachi et al., Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors, ANTICANC R, 20(6C), 2000, pp. 4751-4755
New drugs in recurrent high grade gliomas
Authors: Brandes, AA Pasetto, LM Monfardini, S
Citation: Aa. Brandes et al., New drugs in recurrent high grade gliomas, ANTICANC R, 20(3B), 2000, pp. 1913-1920
Endocrine dysfunctions in patients treated for brain tumors: incidence andguidelines for management
Authors: Brandes, AA Pasetto, LM Lumachi, F Monfardini, S
Citation: Aa. Brandes et al., Endocrine dysfunctions in patients treated for brain tumors: incidence andguidelines for management, J NEURO-ONC, 47(1), 2000, pp. 85-92
Temozolomide in patients with high grade gliomas
Authors: Brandes, AA Pasetto, LM Vastola, F Monfardini, S
Citation: Aa. Brandes et al., Temozolomide in patients with high grade gliomas, ONCOL-BASEL, 59(3), 2000, pp. 181-186
Chemotherapy in patients with recurrent and progressive central neurocytoma
Authors: Brandes, AA Amista, P Gardiman, M Volpin, L Danieli, D Guglielmi, B Carollo, C Pinna, G Turazzi, S Monfardini, S
Citation: Aa. Brandes et al., Chemotherapy in patients with recurrent and progressive central neurocytoma, CANCER, 88(1), 2000, pp. 169-174
Procarbazine and high-dose tamoxifen as a second-line regimen in recurrenthigh-grade gliomas: A phase II study
Authors: Brandes, AA Ermani, M Turazzi, S Scelzi, E Berti, F Amista, P Rotilio, A Licata, C Fiorentino, MV
Citation: Aa. Brandes et al., Procarbazine and high-dose tamoxifen as a second-line regimen in recurrenthigh-grade gliomas: A phase II study, J CL ONCOL, 17(2), 1999, pp. 645-650
Medulloblastoma in adults: clinical characteristics and treatment
Authors: Brandes, AA Palmisano, V Monfardini, S
Citation: Aa. Brandes et al., Medulloblastoma in adults: clinical characteristics and treatment, CANC TR REV, 25(1), 1999, pp. 3-12
Reoperation in recurrent high-grade gliomas - Literature review of prognostic factors and outcome
Authors: Brandes, AA Vastola, F Monfardini, S
Citation: Aa. Brandes et al., Reoperation in recurrent high-grade gliomas - Literature review of prognostic factors and outcome, AM J CL ONC, 22(4), 1999, pp. 387-390
Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3
Authors: Lumachi, F Brandes, AA Boccagni, P Polistina, F Favia, G D'Amico, DF
Citation: F. Lumachi et al., Long-term follow-up study in breast cancer patients using serum tumor markers CEA and CA 15-3, ANTICANC R, 19(5C), 1999, pp. 4485-4489
Risultati: 1-19 |